Lin Liao

1.8k total citations
106 papers, 1.1k citations indexed

About

Lin Liao is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Lin Liao has authored 106 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Endocrinology, Diabetes and Metabolism, 42 papers in Molecular Biology and 18 papers in Surgery. Recurrent topics in Lin Liao's work include Diabetes Treatment and Management (19 papers), Thyroid Cancer Diagnosis and Treatment (17 papers) and Metabolism, Diabetes, and Cancer (14 papers). Lin Liao is often cited by papers focused on Diabetes Treatment and Management (19 papers), Thyroid Cancer Diagnosis and Treatment (17 papers) and Metabolism, Diabetes, and Cancer (14 papers). Lin Liao collaborates with scholars based in China, United States and Japan. Lin Liao's co-authors include Jianjun Dong, Jinming Yao, Junyu Zhao, Xiaojun Zhou, Chunmei Xu, Jianjun Dong, Congcong Guo, Wei Zhang, Zhongwen Zhang and Zhipeng Xu and has published in prestigious journals such as Annals of Oncology, British Journal of Pharmacology and Life Sciences.

In The Last Decade

Lin Liao

96 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Liao China 20 461 373 169 129 129 106 1.1k
Chao Zheng China 21 454 1.0× 219 0.6× 221 1.3× 139 1.1× 130 1.0× 80 1.3k
Sri Nagarjun Batchu Canada 20 444 1.0× 288 0.8× 161 1.0× 95 0.7× 82 0.6× 36 1.1k
Chiara Cuccurullo Italy 16 280 0.6× 378 1.0× 255 1.5× 203 1.6× 135 1.0× 30 1.6k
Juhong Yang China 17 406 0.9× 238 0.6× 125 0.7× 134 1.0× 140 1.1× 57 1.0k
Mirco Zucchelli Italy 20 681 1.5× 210 0.6× 138 0.8× 137 1.1× 312 2.4× 38 1.5k
Lucas Opazo-Ríos Spain 12 347 0.8× 200 0.5× 111 0.7× 155 1.2× 82 0.6× 20 1.0k
Weiping Zhang China 16 352 0.8× 142 0.4× 330 2.0× 138 1.1× 96 0.7× 66 988
Kengo Azushima Japan 21 390 0.8× 492 1.3× 226 1.3× 150 1.2× 63 0.5× 94 1.5k
Hiroyuki Unoki‐Kubota Japan 19 697 1.5× 282 0.8× 265 1.6× 220 1.7× 140 1.1× 37 1.6k
Stefan Schäfer Germany 22 659 1.4× 532 1.4× 253 1.5× 88 0.7× 51 0.4× 59 1.7k

Countries citing papers authored by Lin Liao

Since Specialization
Citations

This map shows the geographic impact of Lin Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Liao more than expected).

Fields of papers citing papers by Lin Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Liao. The network helps show where Lin Liao may publish in the future.

Co-authorship network of co-authors of Lin Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Liao. A scholar is included among the top collaborators of Lin Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Liao. Lin Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Guo, Congcong, et al.. (2024). Crosstalk between proximal tubular epithelial cells and other interstitial cells in tubulointerstitial fibrosis after renal injury. Frontiers in Endocrinology. 14. 1256375–1256375. 19 indexed citations
3.
Guo, Congcong, et al.. (2024). High CD133 expression in proximal tubular cells in diabetic kidney disease: good or bad?. Journal of Translational Medicine. 22(1). 159–159. 2 indexed citations
4.
Zhao, Junyu, et al.. (2024). Selenomethionine Suppress the Progression of Poorly Differentiated ThyroidCancer via LncRNA NONMMUT014201/miR-6963-5p/Srprb Pathway. Combinatorial Chemistry & High Throughput Screening. 27(16). 2419–2432. 1 indexed citations
5.
6.
Wang, Fei, et al.. (2023). Selenium and thyroid diseases. Frontiers in Endocrinology. 14. 1133000–1133000. 38 indexed citations
7.
8.
Wang, Haipeng, et al.. (2022). Empagliflozin reduces diffuse myocardial fibrosis by extracellular volume mapping: A meta-analysis of clinical studies. Frontiers in Endocrinology. 13. 917761–917761. 12 indexed citations
9.
Jiang, Shan, Chunmei Xu, Yao Shuai, et al.. (2022). Cdc42 upregulation under high glucose induces podocyte apoptosis and impairs β-cell insulin secretion. Frontiers in Endocrinology. 13. 905703–905703. 10 indexed citations
10.
Wu, Jing, et al.. (2022). The Clinical Characteristics and Gene Mutations of Maturity-Onset Diabetes of the Young Type 5 in Sixty-One Patients. Frontiers in Endocrinology. 13. 911526–911526. 6 indexed citations
11.
Zhao, Junyu, Jinming Yao, Gu He, et al.. (2021). Hypercholesterolemia Is an Associated Factor for Risk of Differentiated Thyroid Cancer in Chinese Population. Frontiers in Oncology. 10. 508126–508126. 7 indexed citations
12.
Liao, Lin, Jie Chen, Chuanfu Zhang, et al.. (2021). LncRNA NEAT1 Promotes High Glucose-Induced Mesangial Cell Hypertrophy by Targeting miR-222-3p/CDKN1B Axis. Frontiers in Molecular Biosciences. 7. 627827–627827. 17 indexed citations
13.
Yao, Jinming, et al.. (2021). The Clinical and Pathological Characteristics of Malignant Struma Ovarii: An Analysis of 144 Published Patients. Frontiers in Oncology. 11. 645156–645156. 37 indexed citations
14.
Xu, Chunmei, et al.. (2021). The Mutations and Clinical Variability in Maternally Inherited Diabetes and Deafness: An Analysis of 161 Patients. Frontiers in Endocrinology. 12. 728043–728043. 33 indexed citations
15.
Zhao, Junyu, Jing Wen, Shengnan Wang, et al.. (2020). Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies. BMC Cancer. 20(1). 788–788. 14 indexed citations
16.
Zhang, Rui, Zhiwei Zou, Xiaojun Zhou, et al.. (2019). Comparative Effects of Three Sulfonylureas (Glibenclamide, Glimepiride, and Gliclazide) on Proliferation and Migration of Vascular Smooth Muscle Cells. Cellular Physiology and Biochemistry. 52(1). 16–26. 5 indexed citations
17.
Zhao, Junyu, et al.. (2018). Statins and Thyroid Carcinoma: a Meta-Analysis. Cellular Physiology and Biochemistry. 47(4). 1422–1431. 11 indexed citations
18.
Wu, Xiaoyun, et al.. (2017). Calcium Dobesilate Prevents Diabetic Kidney Disease by Decreasing Bim and Inhibiting Apoptosis of Renal Proximal Tubular Epithelial Cells. DNA and Cell Biology. 36(4). 249–255. 16 indexed citations
19.
20.
Han, Yi, Xiaojun Zhou, Bo Zhang, et al.. (2016). Association between DPP4 gene polymorphism and serum lipid levels in Chinese type 2 diabetes individuals. Neuropeptides. 60. 1–6. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chao Zheng Breakdown of academic impact, for papers by Sri Nagarjun Batchu Breakdown of academic impact, for papers by Chiara Cuccurullo Breakdown of academic impact, for papers by Juhong Yang Breakdown of academic impact, for papers by Mirco Zucchelli Breakdown of academic impact, for papers by Lucas Opazo-Ríos Breakdown of academic impact, for papers by Weiping Zhang Breakdown of academic impact, for papers by Kengo Azushima Breakdown of academic impact, for papers by Hiroyuki Unoki‐Kubota Breakdown of academic impact, for papers by Stefan Schäfer
Rankless by CCL
2026